Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Antibe Therapeutics Inc(Pre-Merger) T.ATE


Primary Symbol: ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by Pronorvistaon May 05, 2022 12:49pm
167 Views
Post# 34659080

RE:RE:A transcript from the Questions Dan answered at Bloom Burton

RE:RE:A transcript from the Questions Dan answered at Bloom Burton

Depth by Price for T : ATE at 2022-05-05 12:43:43

  Bid Ask
Price
Volume
Orders
0.66
7,000
2
0.68
2,710
2
0.69
1,500
2
0.70
501,750
3
0.71
500
1
0.72
4,500
2
0.74
5,000
2
0.75
500
1
0.77
1,500
1
0.78
4,000
1
Bid
Orders Volume Price
1 500 0.71
3 501,750 0.70
2 1,500 0.69
2 2,710 0.68
2 7,000 0.66

Ask
Price Volume Orders
0.72 4,500 2
0.74 5,000 2
0.75 500 1
0.77 1,500 1
0.78 4,000

<< Previous
Bullboard Posts
Next >>